FDA to study safety of medicines during pregnancy
This article was originally published in Scrip
In a new government/private sector initiative, the US FDA is linking up with outside researchers to study the effects of prescription drugs used during pregnancy. The goal will be to use population-based databases to provide information that is lacking from clinical trials. Some data may be used to help guide regulatory policy, said FDA commissioner Dr Margaret Hamburg.